Cart
sales@molnova.com
Raxofelast
CAS No. 128232-14-4
Raxofelast( —— )
Catalog No. M34690 CAS No. 128232-14-4
Raxofelast (IRFI-016) is a hydrophilic, non-systemic, vitamin-like antioxidant that reduces ischemia-reperfusion injury in testis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 182 | In Stock |
|
| 10MG | 274 | In Stock |
|
| 25MG | 448 | In Stock |
|
| 50MG | 603 | In Stock |
|
| 100MG | 826 | In Stock |
|
| 200MG | 1107 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameRaxofelast
-
NoteResearch use only, not for human use.
-
Brief DescriptionRaxofelast (IRFI-016) is a hydrophilic, non-systemic, vitamin-like antioxidant that reduces ischemia-reperfusion injury in testis.
-
DescriptionRaxofelast (IRFI-016) is a hydrophilic, non-systemic, vitamin-like antioxidant that reduces ischemia-reperfusion injury in testis. Raxofelast is a good candidate compound for stopping oxidative stress after acute testicular torsion. Raxofelast has the potential to treat diabetic complications and atherosclerosis.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetAntioxidant
-
RecptorAntioxidant
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number128232-14-4
-
Formula Weight278.3
-
Molecular FormulaC15H18O5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC1=C2C(OC(CC(O)=O)C2)=C(C)C(C)=C1OC(C)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Dimethylacrylshikoni...
Dimethylacrylshikonin is a promising agent for developing an improved strategy for radiotherapy against tumors.
-
Dihydrolipoic acid
Dihydrolipoic acid, a dithiol-containing carboxylic acid, acts as a general antioxidant that is highly reactive against a variety of reactive oxygen species, including peroxynitirite, hydroxyl radicals, hydrogen peroxide, and hypochlorite, at concentrations ranging from 0.01-0.5 mM.
-
Cosmosiin
Cosmosiin may be beneficial for diabetic complications through their enhanced adiponectin secretion, tyrosine phosphorylation of insulin receptor-β and GLUT4 translocation.
